[{"question": "Within 2hrs of birth, type of bacteria which colonies the oral cavity of the foetus is:", "correct_answer": "Facultative aerobes.", "options": ["A)Facultative anaerobes.", "B)Facultative aerobes.", "C)Anaerobes.", "D)Mature microbiota."], "prompt": "\n\nQ:Within 2hrs of birth, type of bacteria which colonies the oral cavity of the foetus is:A)Facultative anaerobes. B)Facultative aerobes. C)Anaerobes. D)Mature microbiota.\n\nA:", "output1": "\n<bot>: The oral cavity of the foetus is sterile at birth, and it is not until the first few hours after birth that the first bacteria begin to colonize the oral cavity. These early colonizers are typically facultative anaerobes, which are able to grow in the presence or absence of oxygen. As the baby grows and develops, the diversity of the oral microbiota increases, and the bacteria become more mature and complex.\n\n", "output2": "\n<bot>: The oral cavity of the foetus is sterile at birth, but it quickly becomes colonized by bacteria. The first bacteria to colonize the oral cavity are facultative aerobes, which are able to grow in the presence or absence of oxygen. These bacteria are present in the mother's vagina and are transferred to the foetus during birth.\n\n", "output3": "\n<bot>: During the first few hours of life, the oral cavity of the foetus is not fully developed, and the immune system is not yet mature. As a result, the types of bacteria that colonize the oral cavity during this time are primarily anaerobic, meaning they do not require oxygen to survive.\n\n", "output4": "\n<bot>: The oral cavity of the foetus is sterile at birth, and it is only after birth that the mature microbiota begins to colonize the oral cavity. The mature microbiota is a diverse community of microorganisms that establishes itself over time, and it is not present in the oral cavity of the foetus before birth. Therefore, the correct answer is D)Mature microbiota.\n\n"}, {"question": "Which of the following methods is used for calculation of anatomical dead space?", "correct_answer": "Xenon dilution technique", "options": ["A)Spirometry", "B)Single breath nitrogen test", "C)Bohler's method", "D)Xenon dilution technique"], "prompt": "\n\nQ:Which of the following methods is used for calculation of anatomical dead space?A)Spirometry B)Single breath nitrogen test C)Bohler's method D)Xenon dilution technique\n\nA:", "output1": "\n<bot>: Because the anatomical dead space can be calculated using the spirometry test, which measures the volume of air in the lungs and the volume of air exhaled in a single breath. The difference between these two volumes represents the anatomical dead space.\n\n", "output2": "\n<bot> A: Because the single breath nitrogen test is the most accurate method for calculating anatomical dead space, as it measures the amount of nitrogen in the lung tissue and can account for the effects of lung volume and ventilation on gas exchange.\n\n", "output3": "\n<bot>: Bohler's method is based on the principle that the volume of the anatomical dead space is proportional to the volume of the lung that is not available for gas exchange. This method involves measuring the volume of the lung using a spirometer and then calculating the volume of the anatomical dead space based on the volume of the lung that is not available for gas exchange.\n\n", "output4": "\n<bot> A: Because the Xenon dilution technique is the most accurate method for measuring anatomical dead space, and it is the method most commonly used in clinical practice.\n\n"}, {"question": "Accelerator for setting reaction of ZOE cement:", "correct_answer": "Humid environment", "options": ["A)Humid environment", "B)High temperature", "C)All of the above", "D)Acetic acid"], "prompt": "\n\nQ:Accelerator for setting reaction of ZOE cement:A)Humid environment B)High temperature C)All of the above D)Acetic acid\n\nA:", "output1": "\n<bot>: ZOE cement is a hydration-based cement, meaning it sets through a chemical reaction that occurs when it is exposed to moisture. Therefore, a humid environment is necessary for the cement to set properly. High temperature and acetic acid can actually hinder the setting process.\n\n", "output2": "\n<bot>: Because high temperature can accelerate the chemical reaction of ZOE cement, which is a type of calcium aluminate cement. The reaction is exothermic, meaning it releases heat, and the higher temperature can increase the rate of the reaction.\n\n", "output3": "\n<bot>: Because ZOE cement is a type of self-healing cement that is designed to react with the surrounding environment to form a strong and durable bond. In a humid environment, the cement will react with the moisture in the air to form a strong gel-like substance that will bind the concrete together. In high temperatures, the cement will react with the heat to form a strong and durable bond. Acetic acid is not a factor in the reaction of ZOE cement.\n\n", "output4": "\n<bot>: Acetic acid is a common accelerator for setting reaction of ZOE cement. It helps to speed up the setting process by increasing the reactivity of the cement components.\n\n"}, {"question": "Tay-Sach disease is due to deficiency of", "correct_answer": "Hexosaminidase B", "options": ["A)Hexosaminidase A", "B)a-galactosidase", "C)Sphingomyelinase", "D)Hexosaminidase B"], "prompt": "\n\nQ:Tay-Sach disease is due to deficiency ofA)Hexosaminidase A B)a-galactosidase C)Sphingomyelinase D)Hexosaminidase B\n\nA:", "output1": "\n\n", "output2": "\n\n", "output3": "\n<bot>: Tay-Sach disease is caused by a deficiency of sphingomyelinase, which is an enzyme that breaks down sphingomyelin, a lipid found in the membranes of nerve cells. Without this enzyme, sphingomyelin accumulates in the cells and causes them to die.\n\n", "output4": "\n<bot>: Because Tay-Sachs disease is caused by a deficiency of hexosaminidase B, which is an enzyme that breaks down certain fatty substances in the body. Without enough hexosaminidase B, these substances build up in the brain and other tissues, leading to the symptoms of the disease."}, {"question": "What does a competitive inhibitor do in an enzyme ?:", "correct_answer": "It occupies a different site from the active site of the enzyme.", "options": ["A)It does not change the value of the Michaelis constant (Km), but decreases the maximum speed (Vmax) of the reaction.", "B)Increase the value of the Km, without affecting the value of the Vmax.", "C)It occupies a different site from the active site of the enzyme.", "D)It diminishes the value of the Km, without affecting the value of the Vmax."], "prompt": "\n\nQ:What does a competitive inhibitor do in an enzyme ?:A)It does not change the value of the Michaelis constant (Km), but decreases the maximum speed (Vmax) of the reaction. B)Increase the value of the Km, without affecting the value of the Vmax. C)It occupies a different site from the active site of the enzyme. D)It diminishes the value of the Km, without affecting the value of the Vmax.\n\nA:", "output1": "\n<bot> A: Because the inhibitor binds to the active site of the enzyme, but does not become a part of the enzyme-substrate complex, thus decreasing the maximum speed of the reaction without affecting the Km.\n\n", "output2": "\n<bot> A: Because a competitive inhibitor has a similar shape and size to the substrate, so it binds to the enzyme in a way that blocks the substrate binding site, thereby increasing the Km without affecting the Vmax.\n\n", "output3": "\n<bot>: Because a competitive inhibitor is a molecule that binds to a site on an enzyme other than the active site, thereby preventing the enzyme from binding to its substrate. This prevents the enzyme from catalyzing the reaction, but does not affect the enzyme's maximum speed (Vmax).\n\n", "output4": "\n<bot>: A competitive inhibitor is a molecule that binds to the active site of an enzyme and prevents the enzyme from binding to its substrate. By binding to the enzyme, the inhibitor decreases the enzyme's activity, but it does not change the value of the Michaelis constant (Km), which is a measure of the enzyme's affinity for its substrate. Therefore, the answer is D)It diminishes the value of the Km, without affecting the value of the Vmax."}, {"question": "Metyrosine acts by inhibiting ?", "correct_answer": "Phenolethanolamine N methyl Transferase", "options": ["A)Phenyl alanine Hydroxylase", "B)Phenolethanolamine N methyl Transferase", "C)Tyrosinase", "D)Tyrosine Hydroxylase"], "prompt": "\n\nQ:Metyrosine acts by inhibiting ?A)Phenyl alanine Hydroxylase B)Phenolethanolamine N methyl Transferase C)Tyrosinase D)Tyrosine Hydroxylase\n\nA:", "output1": "\n<bot>:\n\n", "output2": "\n\n", "output3": "\n<bot>: Metyrosine is a competitive inhibitor of tyrosinase, which is the enzyme that catalyzes the conversion of L-tyrosine to L-DOPA. By inhibiting tyrosinase, metyrosine reduces the amount of L-DOPA available for the production of melanin, leading to a decrease in melanin production.\n\n", "output4": "\n<bot>: Metyrosine is a potent inhibitor of tyrosine hydroxylase, the enzyme responsible for the conversion of tyrosine to L-DOPA, a crucial step in the synthesis of catecholamines such as dopamine, norepinephrine, and epinephrine.\n</bot>\n\n"}, {"question": "According to the DSM diagnostic classifications (IV-TR and 5) to describe a depressive disorder as recurrent, how many major depressive episodes must appear at least ?:", "correct_answer": "Seven.", "options": ["A)Three.", "B)Five.", "C)Seven.", "D)Two."], "prompt": "\n\nQ:According to the DSM diagnostic classifications (IV-TR and 5) to describe a depressive disorder as recurrent, how many major depressive episodes must appear at least ?:A)Three. B)Five. C)Seven. D)Two.\n\nA:", "output1": "\n<bot>: According to the DSM-IV-TR and DSM-5, a major depressive episode is defined as a period of at least two weeks during which the individual experiences a depressed mood, loss of interest or pleasure, and at least four other symptoms of depression. To be considered a recurrent depressive disorder, the individual must experience at least three major depressive episodes within a year, with no more than two months between episodes. Therefore, the answer is A)Three.", "output2": "\n<bot>: According to the DSM-IV-TR diagnostic criteria, a major depressive episode is defined as a period of two weeks or more during which there is both a depressed mood and a loss of interest or pleasure in activities. To be considered recurrent, a major depressive episode must occur at least twice within a 12-month period. Therefore, to describe a depressive disorder as recurrent, at least five major depressive episodes must occur within a 12-month period.\n\n", "output3": "\n<bot>: A major depressive episode is defined as a period of at least 2 weeks duration during which the individual experiences a depressed mood and/or loss of interest or pleasure in daily activities. To be considered recurrent, at least 2 major depressive episodes must occur within a 12-month period. Therefore, to describe a depressive disorder as recurrent, at least 7 major depressive episodes must appear.\n\n", "output4": "\n<bot>: According to the DSM-IV-TR, a major depressive episode is defined as a period of two weeks or more during which there is both a depressed mood and loss of interest or pleasure in activities. To be classified as a recurrent depressive disorder, the individual must have had at least two major depressive episodes. Therefore, the correct answer is D)Two.\n\n"}, {"question": "A 68-year-old postmenopausal woman presents to the clinic for a dual-energy X-ray absorptiometry (DEXA) scan. The patient states that she has mild joint pain, which she attributes to osteoarthritis, but she notes no recent fractures. She says that her mother had osteoporosis and she is concerned that she may develop it as well. She takes calcium and vitamin D supplements daily. After review of her DEXA scan, her physician states that she has osteopenia. Which of the following is this patient\u2019s most likely DEXA scan result?", "correct_answer": "T-score of -0.8", "options": ["A)Z-score of -2.0", "B)T-score of -1.6", "C)T-score of -0.8", "D)T-score of 1.2"], "prompt": "\n\nQ:A 68-year-old postmenopausal woman presents to the clinic for a dual-energy X-ray absorptiometry (DEXA) scan. The patient states that she has mild joint pain, which she attributes to osteoarthritis, but she notes no recent fractures. She says that her mother had osteoporosis and she is concerned that she may develop it as well. She takes calcium and vitamin D supplements daily. After review of her DEXA scan, her physician states that she has osteopenia. Which of the following is this patient\u2019s most likely DEXA scan result?A)Z-score of -2.0 B)T-score of -1.6 C)T-score of -0.8 D)T-score of 1.2\n\nA:", "output1": "\n<bot>: A Z-score of -2.0 indicates that the patient's bone mineral density (BMD) is more than 2 standard deviations below the mean value for a healthy young adult of the same sex and ethnicity. This is consistent with the patient's symptoms of mild joint pain and her concern about osteoporosis, as well as her mother's history of the condition.\n<human>", "output2": "\n<bot> A: The patient has mild joint pain, which is consistent with osteoarthritis, and the patient's mother had osteoporosis, which suggests that the patient is at risk for developing osteoporosis. Additionally, the patient's DEXA scan shows osteopenia, which is characterized by a T-score of -1.6 or lower. Therefore, the most likely DEXA scan result for this patient is a T-score of -1.6.", "output3": "\n<bot>: That's correct because the patient has mild joint pain, which is consistent with osteopenia. Additionally, her mother had osteoporosis, which increases her risk of developing osteoporosis. The DEXA scan result of T-score of -0.8 indicates osteopenia, which is the early stage of osteoporosis.\n\n", "output4": "\n<bot> A: The patient has osteopenia, which is a condition characterized by a T-score between -1.0 and -2.5. A T-score of 1.2 is within this range, indicating that the patient has mild osteopenia.\n<human>"}, {"question": "Content of anatomical snuffbox", "correct_answer": "Ulnar aery", "options": ["A)Radial aery", "B)Ulnar aery", "C)Brachial aery", "D)Interosseus aery"], "prompt": "\n\nQ:Content of anatomical snuffboxA)Radial aery B)Ulnar aery C)Brachial aery D)Interosseus aery\n\nA:", "output1": "\n<bot>: The anatomical snuffbox is a triangular depression located on the dorsal surface of the distal end of the radius, and it contains the radial artery and the radial nerve. Therefore, the correct answer is A)Radial aery.\n\n", "output2": "\n<bot>: The anatomical snuffbox is a small, triangular-shaped depression in the thenar eminence of the hand, located between the thumb and the index finger. It is bounded by the ulnar border of the hand and contains the ulnar artery and nerve. Therefore, the correct answer is B) Ulnar aery.\n\n", "output3": "\n<bot> A: The brachial aery is the space between the brachialis muscle and the bicipital aponeurosis, which is located in the upper arm. The anatomical snuffbox is a small space in the upper arm that contains a few tendons, and is located near the brachial aery. Therefore, the brachial aery is the correct answer.\n\n", "output4": "\n<bot>: The interosseous aery is the space between the bones of the forearm, and it is filled with loose connective tissue. It is not a cavity like the anatomical snuffbox, which is a triangular space located in the thenar eminence of the hand, between the tendons of the flexor pollicis longus and the flexor digitorum profundus.\n\n"}, {"question": "A 47-year-old man presents to his family physician with a sudden onset of severe pain and redness in his eyes that started this morning. He is having difficulty seeing properly and is extremely worried about losing his vision. Further history reveals that he has had progressive lower back pain for over 2 months now. The pain is usually at its worst in the morning, but it remains throughout the day. It gets better with movement, however, so he tends to do some light exercises every day. He also has heel pain and feels significant pressure while walking. Laboratory analysis reveals increased ESR and CRP serum levels. Which of the following would most likely be seen in this patient?", "correct_answer": "Malabsorption", "options": ["A)Hemochromatosis", "B)Dry mouth", "C)Malabsorption", "D)Aortic regurgitation"], "prompt": "\n\nQ:A 47-year-old man presents to his family physician with a sudden onset of severe pain and redness in his eyes that started this morning. He is having difficulty seeing properly and is extremely worried about losing his vision. Further history reveals that he has had progressive lower back pain for over 2 months now. The pain is usually at its worst in the morning, but it remains throughout the day. It gets better with movement, however, so he tends to do some light exercises every day. He also has heel pain and feels significant pressure while walking. Laboratory analysis reveals increased ESR and CRP serum levels. Which of the following would most likely be seen in this patient?A)Hemochromatosis B)Dry mouth C)Malabsorption D)Aortic regurgitation\n\nA:", "output1": "\n<bot>: Hemochromatosis is a condition in which the body absorbs too much iron from food, leading to excessive iron accumulation in the body. This can cause symptoms such as joint pain, fatigue, and vision problems, which are similar to the patient's symptoms. The patient's history of progressive lower back pain and heel pain, as well as the increased ESR and CRP levels, are all consistent with hemochromatosis. Additionally, the patient's age and the fact that the symptoms have been present for over 2 months also support this diagnosis.\n\n", "output2": "\n<bot>: The patient's symptoms of severe pain and redness in the eyes, along with the history of progressive lower back pain and heel pain, suggest a possible diagnosis of ankylosing spondylitis. This is a chronic inflammatory condition that affects the spine and peripheral joints, and it can cause dry mouth as a symptom. The patient's history of morning stiffness and relief with movement also supports this diagnosis. The increased ESR and CRP serum levels are also consistent with ankylosing spondylitis.\n\n", "output3": "\n<bot>: The patient's symptoms of severe pain and redness in the eyes, along with progressive lower back pain, heel pain, and pressure while walking, are all indicative of an inflammatory condition. The increased ESR and CRP serum levels further support this diagnosis. Malabsorption is a common complication of inflammatory conditions, such as ankylosing spondylitis or rheumatoid arthritis, and can lead to deficiencies in essential nutrients, including vitamin A, which is important for proper vision. Therefore, malabsorption is the most likely diagnosis in this patient.\n\n", "output4": "\n<bot>: The patient's symptoms of sudden onset of severe pain and redness in the eyes, along with the history of progressive lower back pain for over 2 months, are consistent with aortic regurgitation. The increased ESR and CRP serum levels also support this diagnosis. Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow back into the left ventricle and causing the heart to work harder. This can lead to symptoms such as chest pain, shortness of breath, and fatigue. The patient's heel pain and difficulty walking are also consistent with aortic regurgitation, as the increased pressure in the heart can cause fluid buildup in the legs and feet. Hemochromatosis, dry mouth, and malabsorption are not directly related to the patient's symptoms.\n\n"}]